Kovet โคand Royal Canin Partner to Enhance Veterinaryโ Diagnostics with AI-Powered Platform
HELSINKI, FINLAND – โคNovember 21, 2023 – Finnishโค Health Tech company Kovet and royal Canin have announced a collaboration to integrate Kovet’s AI-based clinical decision support tools with Royalโข Canin’sโข veterinary network. The partnership aims to improve diagnostic accuracy, clinic efficiency, and ultimately,โข pet health.
the โcollaboration will initiallyโข launch as a โขpilot project, โขwithโ a worldwide market launch slatedโฃ for the fourth quarter ofโ 2025 andโ full โขmarket extension in 2026.Kovet’s platform assists veterinarians โฃand their teams in making informed clinical decisions thru AI-driven analysis.
“This cooperation โreflects our common โvisionโ of supporting โคveterinariansโ with smart โtools that facilitate clinical decision-making and improve the standard of treatment,” โsaid Dr. โฃJohanna โRelatives, CEO of Kovet.
Royal Canin intends to โคleverage Kovet’s technology to further โคits mission of improving pet health โขthrough science and partnerships. “We at โRoyal Caninโ want to support veterinarians andโข theirโ teams with the best โฃavailable tools. The platform from KKOVET is perfectly in line with our mission to improve the health of โpets through science and partnerships. We are pleased to be able to make this solution more clinics โavailable to achieve our goal: aโฃ betterโค world โfor pets,” stated Dr. Brent Mayabb, Globalโฃ Chief Medical Officer atโข Royal Canin.
Kovet currently serves thousands โขofโค clinics globally, aidingโฃ veterinarians in faster โand โคmore precise diagnoses. royal Canin,a part ofโ Mars Incorporated,is a global leader in pet โขhealth nutrition,founded in 1968 by French veterinarian Dr.โข Jean Cathary. โ
The companies emphasize โthat the original language โpublication is the legally โคvalid version,andโ translations โคare provided for improved dialog.
